UroGen Pharma
URGN
URGN
138 hedge funds and large institutions have $386M invested in UroGen Pharma in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.54% more ownership
Funds ownership: 83.42% → 85.96% (+2.5%)
8% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 39
13% less capital invested
Capital invested by funds: $446M → $386M (-$59.5M)
Holders
138
Holding in Top 10
4
Calls
$896K
Puts
$223K
Top Buyers
| 1 | +$18.6M | |
| 2 | +$14.6M | |
| 3 | +$13.1M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.34M |
| 5 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$9.27M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$13.3M | |
| 3 | -$12.7M | |
| 4 |
Millennium Management
New York
|
-$9.09M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.6M |